Learn about the ENGAGE2024 Study, an investigational 24 hour treatment for acute pain.
Find a Clinical Trial
Women with symptoms of interstitial cystitis (IC) or bladder pain syndrome (BPS) – who are in acute pain- may qualify for a study.
Currently Enrolling
Safety and Efficacy Study of VNX001 Compared to Its Individual Components (Lidocaine and Heparin) or Placebo in Subjects With IC/BPS
Locations Available: 9
Conditions: Interstitial Cystitis, Bladder Pain Syndrome
Age: ≥ 18 Years
Safety, Efficacy, and Frequency of Administration of VNX001 in the Treatment of Interstitial Cystitis / Bladder Pain Syndrome (IC/BPS)
Locations Available: 3
Conditions: Interstitial Cystitis, Bladder Pain Syndrome
Age: ≥ 18 Years
Am I Eligible?
Must be male or female, 18 years of age or older
Moderate-to-severe bladder pain for at least 9 months
Have had bladder anesthetic treatments in the past
Be advised you will have to read, understand, and sign an informed consent form, and be prepared to answer additional questions regarding your symptoms and pain levels to confirm your eligibility.
Why Participate?
Compensation:
Receive compensation for time and travel
Study Medication & Care:
Get study medication and care at no cost
Expert Monitoring:
Regular monitoring by a board-certified physician